These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

471 related items for PubMed ID: 2878044

  • 21. Immunomodulatory role of IL-4 on the secretion of Ig by human B cells.
    Splawski JB, Jelinek DF, Lipsky PE.
    J Immunol; 1989 Mar 01; 142(5):1569-75. PubMed ID: 2493049
    [Abstract] [Full Text] [Related]

  • 22. TGF beta down-regulates TLiSA1 expression and inhibits the differentiation of precursor lymphocytes into CTL and LAK cells.
    Jin B, Scott JL, Vadas MA, Burns GF.
    Immunology; 1989 Apr 01; 66(4):570-6. PubMed ID: 2541074
    [Abstract] [Full Text] [Related]

  • 23. Transforming growth factor-beta 1 selectively inhibits IL-3-dependent mast cell proliferation without affecting mast cell function or differentiation.
    Broide DH, Wasserman SI, Alvaro-Gracia J, Zvaifler NJ, Firestein GS.
    J Immunol; 1989 Sep 01; 143(5):1591-7. PubMed ID: 2527268
    [Abstract] [Full Text] [Related]

  • 24. Inhibitory influence of IL-4 on human B cell responsiveness.
    Jelinek DF, Lipsky PE.
    J Immunol; 1988 Jul 01; 141(1):164-73. PubMed ID: 2837507
    [Abstract] [Full Text] [Related]

  • 25. Transforming growth factor-beta 1 is required for secretion of IgG of all subclasses by LPS-activated murine B cells in vitro.
    Snapper CM, Waegell W, Beernink H, Dasch JR.
    J Immunol; 1993 Nov 01; 151(9):4625-36. PubMed ID: 8409423
    [Abstract] [Full Text] [Related]

  • 26. Transforming growth factor beta 1 functions in monocytic differentiation of hematopoietic cells through autocrine and paracrine mechanisms.
    Turley JM, Falk LA, Ruscetti FW, Kasper JJ, Francomano T, Fu T, Bang OS, Birchenall-Roberts MC.
    Cell Growth Differ; 1996 Nov 01; 7(11):1535-44. PubMed ID: 8930403
    [Abstract] [Full Text] [Related]

  • 27. Human B cell proliferation and Ig secretion induced by recombinant CD40 ligand are modulated by soluble cytokines.
    Armitage RJ, Macduff BM, Spriggs MK, Fanslow WC.
    J Immunol; 1993 May 01; 150(9):3671-80. PubMed ID: 8097223
    [Abstract] [Full Text] [Related]

  • 28. Interleukin 4 strongly augments or inhibits DNA synthesis and differentiation of B-type chronic lymphocytic leukemia cells depending on the co-stimulatory activation and progression signals.
    Carlsson M, Sundström C, Bengtsson M, Tötterman TH, Rosén A, Nilsson K.
    Eur J Immunol; 1989 May 01; 19(5):913-21. PubMed ID: 2525477
    [Abstract] [Full Text] [Related]

  • 29. Mechanism for transforming growth factor beta and IL-2 enhancement of IgA expression in lipopolysaccharide-stimulated B cell cultures.
    Lebman DA, Lee FD, Coffman RL.
    J Immunol; 1990 Feb 01; 144(3):952-9. PubMed ID: 2295822
    [Abstract] [Full Text] [Related]

  • 30. Regulation of B cell maturation and differentiation. I. Suppression of pokeweed mitogen-induced B cell differentiation by tumor necrosis factor (TNF).
    Kashiwa H, Wright SC, Bonavida B.
    J Immunol; 1987 Mar 01; 138(5):1383-90. PubMed ID: 2949015
    [Abstract] [Full Text] [Related]

  • 31. In vitro transformation by Epstein-Barr virus induces a switch in growth factor and anti-IgM responsiveness in a human leukemic B cell clone.
    Janssen O, Gillis S, Kabelitz D.
    Eur J Immunol; 1990 Jan 01; 20(1):7-14. PubMed ID: 2155117
    [Abstract] [Full Text] [Related]

  • 32. Differential regulation of C alpha 1 and C alpha 2 germ-line and mature mRNA transcripts in human peripheral blood B cells.
    Kitani A, Strober W.
    J Immunol; 1994 Aug 15; 153(4):1466-77. PubMed ID: 8046226
    [Abstract] [Full Text] [Related]

  • 33. Evidence that TGF-beta can inhibit human T-lymphocyte proliferation through paracrine and autocrine mechanisms.
    Fox FE, Ford HC, Douglas R, Cherian S, Nowell PC.
    Cell Immunol; 1993 Aug 15; 150(1):45-58. PubMed ID: 8393732
    [Abstract] [Full Text] [Related]

  • 34. IL-2 dependence of the promotion of human B cell differentiation by IL-6 (BSF-2).
    Splawski JB, McAnally LM, Lipsky PE.
    J Immunol; 1990 Jan 15; 144(2):562-9. PubMed ID: 2295801
    [Abstract] [Full Text] [Related]

  • 35. Transforming growth factor-beta is a potent immunosuppressive agent that inhibits IL-1-dependent lymphocyte proliferation.
    Wahl SM, Hunt DA, Wong HL, Dougherty S, McCartney-Francis N, Wahl LM, Ellingsworth L, Schmidt JA, Hall G, Roberts AB.
    J Immunol; 1988 May 01; 140(9):3026-32. PubMed ID: 3129508
    [Abstract] [Full Text] [Related]

  • 36. Normal B cell precursors responsive to recombinant murine IL-7 and inhibition of IL-7 activity by transforming growth factor-beta.
    Lee G, Namen AE, Gillis S, Ellingsworth LR, Kincade PW.
    J Immunol; 1989 Jun 01; 142(11):3875-83. PubMed ID: 2785567
    [Abstract] [Full Text] [Related]

  • 37. Regulation of mucosal B cell immunoglobulin secretion by intestinal epithelial cell-derived cytokines.
    Goodrich ME, McGee DW.
    Cytokine; 1998 Dec 01; 10(12):948-55. PubMed ID: 10049518
    [Abstract] [Full Text] [Related]

  • 38. Transforming growth factor beta 1 acts as an autocrine-negative growth regulator in colon enterocytic differentiation but not in goblet cell maturation.
    Hafez MM, Infante D, Winawer S, Friedman E.
    Cell Growth Differ; 1990 Dec 01; 1(12):617-26. PubMed ID: 2288877
    [Abstract] [Full Text] [Related]

  • 39. The Ba fragment of complement factor B inhibits human B lymphocyte proliferation.
    Ambrus JL, Peters MG, Fauci AS, Brown EJ.
    J Immunol; 1990 Mar 01; 144(5):1549-53. PubMed ID: 2307833
    [Abstract] [Full Text] [Related]

  • 40. The roles of IL-4, TGF-beta and LPS in IgA switching.
    Kunimoto DY, Ritzel M, Tsang M.
    Eur Cytokine Netw; 1992 Mar 01; 3(4):407-15. PubMed ID: 1421013
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 24.